Cargando…
Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
SIMPLE SUMMARY: Pancreatic adenocarcinoma (PAAD) is a devastating malignant tumor with a dismal prognosis. How to evaluate the prognosis efficiently is urgently needed for PAAD patients. Both activated autophagy and Wnt/β-catenin signaling pathway were reported to show significant relevancy with PAA...
Autores principales: | Lyu, Hao, Zhang, Jiahui, Wei, Qian, Huang, Yuan, Zhang, Rui, Xiao, Shuai, Guo, Dong, Chen, Xing-Zhen, Zhou, Cefan, Tang, Jingfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952986/ https://www.ncbi.nlm.nih.gov/pubmed/36829596 http://dx.doi.org/10.3390/biology12020319 |
Ejemplares similares
-
LncRNA PVT1 promotes gemcitabine resistance of pancreatic cancer via activating Wnt/β-catenin and autophagy pathway through modulating the miR-619-5p/Pygo2 and miR-619-5p/ATG14 axes
por: Zhou, Cefan, et al.
Publicado: (2020) -
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023) -
An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021) -
A Panel of 12-lncRNA Signature Predicts Survival of Pancreatic Adenocarcinoma
por: Zhang, Huo, et al.
Publicado: (2019) -
FOXO1-regulated lncRNA LINC01197 inhibits pancreatic adenocarcinoma cell proliferation by restraining Wnt/β-catenin signaling
por: Ling, Jing, et al.
Publicado: (2019)